682
Participants
Start Date
October 31, 2004
Primary Completion Date
February 28, 2009
Study Completion Date
February 28, 2009
Standard Care
CRVO: observation; BRVO: standard care
intravitreal triamcinolone injection
1 mg dose
intravitreal triamcinolone injection
4 mg
University of Wisconsin, Madison
Collaborators (1)
National Eye Institute (NEI)
NIH
Allergan
INDUSTRY
The Emmes Company, LLC
INDUSTRY